tenidap
This page covers all tenidap drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Prostaglandin G/H synthase 1.
Targets
Phase 2 pipeline (1)
- TENIDAP · Immunology
TENIDAP works by inhibiting the enzyme Prostaglandin G/H synthase 1, which plays a key role in the production of inflammatory mediators.
Patent intelligence
- tenidap patent landscape — aggregated cliff calendar, attackable patents, originator estates